AdimFlu-V

BIOLOGICAL2 trials

Sponsors

Adimmune Corporation

Conditions

Influenza

Phase 3

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

CompletedNCT01755364

Adimmune CorporationInfluenza

Start: 2012-11-01End: 2013-03-31Updated: 2018-07-16

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects

CompletedNCT01759654

Adimmune CorporationInfluenza

Start: 2012-10-24End: 2013-03-31Updated: 2018-07-16